Markets:

Overview

News

Currencies

International

Treasuries

(CSE:DMED)

0.1650 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about DMED

< Previous 1 2 Next >

DiagnaMed Enters Acquisition Agreement to Acquire Colchester East Natural Hydrogen Project in Nova Scotia

December 10, 2025

Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is...

Via Newsfile

DiagnaMed and QIMC Confirm Major Expansion of Hydrogen Zone by Over 11 Kilometers in Ontario's Temiscamingue Graben

October 27, 2025

Toronto, Ontario--(Newsfile Corp. - October 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the...

Via Newsfile

Topics Artificial Intelligence

DiagnaMed and QIMC Confirm Major Discovery of Widespread Natural Hydrogen System in Ontario's Temiscamingue Graben

October 14, 2025

209 of 456 Soil Samples Exceed 500 ppm Hydrogen (H2), Including Multiple Readings Over 2,000 ppm - A Major Step...

Via Newsfile

Topics Artificial Intelligence

DiagnaMed Holdings Corp. and Quebec Innovative Materials Corp. Sign Memorandum of Understanding with Temiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydrogen Corridor

October 08, 2025

Toronto, Ontario--(Newsfile Corp. - October 8, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the...

Via Newsfile

DiagnaMed Strengthens Leadership Team and Confirms Completion of Extensive Hydrogen Soil Sampling Program in Ontario's Temiscamingue Graben

September 30, 2025

Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the...

Via Newsfile

Topics Climate Change

DiagnaMed Congratulates QIMC on Quebec Drill Permit Approval and Announces Significant Progress on Ontario Clean Natural Hydrogen Soil Sampling Program

July 24, 2025

Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") proudly...

Via Newsfile

DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants

July 21, 2025

Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is...

Via Newsfile

DiagnaMed Announces Chief Financial Officer Transition

July 16, 2025

Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") announces that Jing...

Via Newsfile

DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board

July 03, 2025

Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) ("DiagnaMed" or the "Company"), is pleased to...

Via Newsfile

DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben

June 17, 2025

Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a Canadian technology...

Via Newsfile

DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario

June 12, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology

June 05, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District

May 29, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program

April 01, 2025

From Revive Therapeutics Ltd.

Via GlobeNewswire

DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis

March 03, 2025

Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading...

Via Newsfile

Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program

March 03, 2025

From Revive Therapeutics Ltd.

Via GlobeNewswire

DiagnaMed Announces LIFE Offering of up to $510,000

February 27, 2025

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a leading...

Via Newsfile

Topics Artificial Intelligence

DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC

February 27, 2025

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"),...

Via Newsfile

Topics Emissions

DiagnaMed Advances Hydrogen Energy Technology Innovation

February 19, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production

January 22, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Announces Resignation of Director and Grant of Stock Options

January 08, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project

January 08, 2025

A Strategic collaboration to Accelerate Clean Natural Hydrogen Innovation

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation

January 07, 2025

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water

November 14, 2024

Advancing hydrogen for medical and industrial uses

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement

November 13, 2024

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen

November 07, 2024

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Advancing the Medical Potential of Hydrogen

October 30, 2024

Focusing on novel molecular hydrogen therapies for brain health

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Expands with Drug and Clinical Research AI Platform

August 21, 2024

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function

August 15, 2024

From DiagnaMed Holdings Corp.

Via GlobeNewswire

DiagnaMed Announces LIFE Offering of up to $650,000

May 15, 2024

From DiagnaMed Holdings Corp.

Via GlobeNewswire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.